To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Digging into KKR’s $1.2b-plus deal for Lightyear’s Therapy Brands, Another big LBO opportunity emerges in Medline Industries
Behind KKR's $1.25 billion Therapy Brands' buyout and Medline Industries is exploring a sale that could value it as much as $30 billion.
